Spondylitis Association of America
    
 
Section Home
 
News Archive
 
Press Releases
 
SAA's Legislative Action Center
 
Special Report:
TNF-a Inhibitors
Enbrel, Remicade
and Humira

The Latest News in Rheumatology

11/27/2002

Efficacy of Infliximab in Refractory Ankylosing Spondylitis: Results of a Six-Month Open-Label Study

Mail-Order Drugs Get High Marks, Some Glitches


Efficacy of Infliximab (Remicade®) in Refractory Ankylosing Spondylitis: Results of a Six-Month Open-Label Study

This study shows Remicade® showed remarkable efficiacy in a large group of severely affected axial-AS patients who did not respond well to conventional therapy. M. Breban, MD and colleagues published their results in the recent issue of Rheumatology.

Results: 50 patients (76% male, 87% HLA-B27 positive, median age 35 years, median disease duration 13 years) with active AS took part in the study. Patients received three infusions of Remicade® (5mg/kg) at weeks 0, 2, and 6, and were monitored until week 24. Methotrexate was not administered in combination with Remicade (as recommended in RA and used by some rheumatologists for AS).

The majority of the patients reached "partial remisision", and 86% of the patients had reached their maximal improvement by week 12.

75% of the patients experienced clear relapse during the study period. Researchers believe this implies that Remicade® generally had a "transient effect on disease evolution", and that repeated infusions are likely to be required to maintain the efficacy of the drug.

The researchers found that relapse usually occurred after discontinuation of the drug, but almost one-third of completers were still free of relapse four months after the last infusion.

They say that it cannot be ruled out that the addition of methotrexate could improve the extent or duration of efficacy of Remicade®--further studies must be completed before conclusions can be drawn.

This study found no serious infection (such as tuberculosis) which have recently been reported to occur at low but presumably increased frequency in patients treated with Remicade®. The researchers relate this to the low number of patients included in this study.

Back to Top

Mail-Order Drugs Get High Marks, Some Glitches

New York (Reuters Health)-- A new survey found that an overwhelming percentage of patients using mail-order pharmacies to fill prescriptions say that on the whole, they are highly satisfied with the option. However, the report shows far less enthusiasm about the timeliness of the prescription deliveries, the ability of customer service to answer questions, and all aspects of mail-service pharmacies Internet services.

This survey underscores what pharmacy benefit managers (PMB's) claim are advantages of mail service--that it's often more convenient and less costly for patients, and delivers a high quality of care. PMB's are companies that negotiate on behalf of clients to get drug discounts.

Many health plan sponsors see home delivery as part of the solution to rising healthcare costs. Patients often pay the same co-payment for a 90-day supply of medication by mail as they do for a 30-day supply filled at their local pharmacy, which could reduce patients' out-of-pocket expenses.

The Pharmacy Benefit Management Institute, an independent organization that conducts research for the PMB industry) surveyed 13,000 people nationwide who use mail-service pharmacies as part of a managed prescription drug benefit program.

  • 88% said they were pleased with overall performance of their male-service pharmacy.
  • 70% were very satisfied.
  • 95% claimed that they use mail-service because they pay less than they would at a retail pharmacy.
  • 82% use mail-service because it is more convenient than a retail pharmacy.
  • Half of all respondents said they use mail-service because their benefit provider requires them to do so (meaning mandate also appears to be a significant driving factor in mail-service).
  • 65% were highly satisfied with the timeliness of their prescription delivery. (This area of performance showed the greatest gap in satisfaction)
  • 62% were highly satisfied with the ease of reaching a pharmacist.

Crystal Wright, a spokeswoman for the National Association of Chain Drug Stores, says that most Americans live within 5 miles of a drugstore where they can get help from a pharmacist if they need it. "Consumers should ask themselves, 'If I have a very serious problem or question about a medication, how easy is it for me to get in touch with a real, live pharmacist rather than a customer service representative?" asks Wright. She says that for very ill patients or those taking multiple medications, it can be a problem when they're forced to use mail-order for financial reasons, and "taken out of the retail setting where they have access to a pharmacist."

Mail service accounted for 15.7% of all retail sales in 2001 in the U.S., making it a booming business.

Back to Top


Join SAA   |    Educational Materials   |    Contact Us   |    Site Map   |    Privacy Statement
© 2008 Spondylitis Association of America, All Rights Reserved